Vitamin D - A novel role in pregnancy

Biopolymers and Cell

Volumn 26, Issue 2, 2010, Pages 97-104

  Arora, Chander P ^a,b   Hobel, C J ^a,b  

^a BURNS AND ALLEN RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Immune response; Pregnancy; Vitamin D

Indexed keywords

VITAMIN D;

CHRONIC DISEASE; DISEASE PREDISPOSITION; HUMAN; INFECTION SENSITIVITY; INFLAMMATORY DISEASE; PLACENTA DEVELOPMENT; PREECLAMPSIA; PREGNANCY; PREGNANT WOMAN; PREMATURE LABOR; REVIEW; RISK FACTOR; SKIN PIGMENTATION; SUN EXPOSURE; VITAMIN D DEFICIENCY;

EID: 77952155500     PISSN: 02337657     EISSN: 19936842     Source Type: Journal    
DOI: 10.7124/bc.00014B     Document Type: Article

References (54)

1. Bodnar L. M., Simhan H. N., Powers R. W., Frank M. P., Cooperstein E., Roberts, J. M. High prevalence of vitamin D insufficiency in black and white pregnant women residing in the northern United States and their neonates. J. Nutr. 2007. 137, N 2. P. 447-452.
2. Holick M. F. Resurrection of vitamin D deficiency and rickets. J. Clin. Invest. 2006. 116, N 8. P. 2062-2072.
3. Hollis B. W., Wagner C. L. Nutritional vitamin D status du-ring pregnancy: reasons for concern CMAJ Canad. Med. Assoc. J. 2006. 174, N 9. P. 1287-1290.
4. Hollis B. W., Wagner C. L. Vitamin D deficiency during preg- nancy: an ongoing epidemic Amer. J. Clin. Nutr. 2006. 84, N 2. P. 273.
5. Chapuy M. C., Preziosi P., Maamer M., Arnaud S., Galan P., Hercberg S., Meunier P. J. Prevalence of vitamin D insufficiency in an adult normal population Osteopor. Int. 1997. 7, N 5. P. 439-443.
6. Dawson-Hughes B., Heaney R. P., Holick M. F., Lips P., Meunier P. J., Vieth R. Estimates of optimal vitamin D status Osteopor. Int. 2005. 16, N 7. P. 713-716.
7. Stene L. C., Joner G., and Norwegian Childhood Diabetes Study Group. Use of cod liver oil during the first year of life isassociated with lower risk of childhood-onset type 1 diabetes: a large, population-based, case-control study. Am. J. Clin. Nutr. 2003. 78, N 6. P. 1128-1134.
8. Camargo C. A. Jr., Rifas-Shiman S. L., Litonjua A. A., Rich- Edwards J. W., Weiss S. T., Gold D. R., Kleinman K., Gillman M. W. Maternal intake of vitamin D during pregnancy and risk of recurrent wheeze in children at 3 y of age. Am. J. Clin. Nutr. 2007. 85, N 3. P. 788-795.
9. McGrath J. Hypothesis: is low prenatal vitamin D a risk-modifying factor for schizophrenia? Schizophr. Res. 1999. 40, N 3. P. 173-177.
10. McGrath J., Saari K., Hakko H., Jokelainen J., Jones P., Jar- velin M. R., Chant D., Isohanni M. Vitamin D supplementation during the first year of life and risk of schizophrenia: a Finnish birth cohort study Schizophr. Res. 2004. 67, N 2-3. P. 237-245.
11. Evans K. N., Bulmer J. N., Kilby M. D., Hewison M. Vitamin D and placental-decidual function J. Soc. Gynecol. Invest. 2004. 11, N 5. P. 263-271.
12. Romero R., Espinoza J., Goncalves L. F., Kusanovic J. P., Friel L. A., Nien J. K. Inflammation in preterm and term labour and delivery Semin. Fetal and Neonat. Med. 2006. 11, N 5. P. 317-326.
13. Romero R., Espinoza J., Goncalves L. F., Kusanovic J. P., Friel L., Hassan S. The role of inflammation and infection in preterm birth Semin. Reproduct. Med. 2007. 25, N 1. P. 21-39.
14. Hillier S. L., Witkin S. S., Krohn M. A., Watts D. H., Kiviat N. B., Eschenbach D. A. The relationship of amniotic fluid cytokines and preterm delivery, amniotic fluid infection, histologic chorioamnionitis, and chorioamnion infection. Obstet. and Gynecol. 1993. 81, N 6. P. 941-948.
15. Gravett M. G., Novy M. J., Rosenfeld R. G., Reddy A. P., Jacob T., Turner M., McCormack A., Lapidus J. A., Hitti J., Eschenbach D. A., Roberts C. T. Jr., Nagalla S. R. Diagnosis of intra-amniotic infection by proteomic profiling and identification of novel biomarkers. JAMA. 2004. 292, N 4. P. 462-469.
16. El-Shazly S., Makhseed M., Azizieh F., Raghupathy R. Increased expression of pro-inflammatory cytokines in placentas of women undergoing spontaneous preterm delivery or premature rupture of membranes. Am. J. Reprod. Immun. 2004. 52, N 1. P. 45-52.
17. Blank V., Hirsch E., Challis J. R., Romero R., Lye S. J. Cytokine signaling, inflammation, innate immunity and preterm labour - a workshop report. Placenta. 2008. 29, Suppl 1. P. 102-104.
18. Gomez R., Romero R., Edwin S. S., David C. Pathogenesis of preterm labor and preterm premature rupture of membranes associated with intraamniotic infection Infect. Dis. Clin. North Amer. 1997. 11, N 1. P. 135-176.
19. Fischer D., Schroer A., Ludders D., Cordes T., Bucker B., Reichrath J., Friedrich M. Metabolism of vitamin D3 in the placental tissue of normal and preeclampsia complicated pregnancies and premature births. Clin. Exp. Obstet. Gynecol. 2007. 34, N 2. P. 80-84.
20. Diaz L., Arranz C., Avila E., Halhali A., Vilchis F., Larrea F. Expression and activity of 25-hydroxyvitamin D-1 alpha-hydroxylase are restricted in cultures of human syncytiotrophoblast cells from preeclamptic pregnancies. J. Clin. Endocrinol. Metabol. 2002. 87, N 8. P. 3876-3882.
21. Hypponen E. Vitamin D for the prevention of preeclampsia? A hypothesis. Nutr. Rev. 2005. 63, N 7. P. 225-232.
22. Zehnder D., Evans K. N., Kilby M. D., Bulmer J. N., Innes B. A., Stewart P. M., Hewison M. The ontogeny of 25-hydroxy-vitamin D(3) 1a-hydroxylase expression in human placenta and deciduas. Am. J. Pathol. 2002. 161, N 1. P. 105-114.
23. Nesby-O’Dell S., Scanlon K. S., Cogswell M. E., Gillespie C., Hollis B. W., Looker A. C., Allen C., Doughertly C., Gunter E. W., Bowman B. A. Hypovitaminosis D prevalence and determinants among African American and white women of reproductive age: third Nat. Health and Nutr. Examination Survey, 1988-1994 Am. J. Clin. Nutr. 2002. 76, N 1. P. 187-192.
24. Hollis B. W., Wagner C. L. Assessment of dietary vitamin D requirements during pregnancy and lactation Amer. J. Clin. Nutr. 2004. 79, N 5. P. 717-726.
25. Arora C. P., Hobel C. J. Vitamin D and IL-6 in pregnancies with subsequent preterm birth Reprod. Sci. 2010. 17. 179À-180À. Sage Publ.
26. Hobel C. J., Arora C. P., Adeniji A., Arora P., Jackman S. E., Miadel O., Baldiyan L. Circulating levels of vitamin D and IL-6 in pregnancies with IUGR Reprod. Sci. 2008. 15, N 2, suppl. 121A-122A. Sage Publ.
27. Holick M. F. Vitamin D: importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis. Am. J. Clin. Nutr. 2004. 79, N 3. P. 362-371.
28. Clemens T. L., Adams J. S., Henderson S. L., Holick M. F. Increased skin pigment reduces the capacity of skin to synthesise vitamin D3. Lancet. 1982. 319, N 8263. P. 74-76.
29. Centers for Disease Control and Prevention (CDC). Differences in infant mortality between blacks and whites - United States, 1980-1991. MMWR - Morbidity & Mortality Weekly Report. 1994. 43, N 16. P. 288-289.
30. Arora C. P., Adeniji A., Jackman S. E., Forooghi B., Mosta- dim I., Yadegari P., Hobel C. J. Reduced plasma levels of vitamin D in Caucasian women at term are associated with increased rate of infection Reprod. Sci. 2008. 15, N 2, suppl. 183A. Sage Publ.
31. Adeniji A., Arora C. P., Baldiyan L., Miadel O., Arora P., Or- tega M., Le A., Koenig M., Hobel C. J. Reduced vitamin D levels in African American pregnancies are associated with increased rate of infection Reprod. Sci. 2008. 15, N 2, suppl. 187A. Sage Publ.
32. Evans K. N., Nguyen L., Chan J., Innes B. A., Bulmer J. N., Kilby M. D., Hewison M. Effects of 25-hydroxyvitamin D3 and 1,25-dihydroxyvitamin D3 on cytokine production by human decidual cells Biol. Reprod. 2006. 75, N 6. P. 816-822.
33. Mathieu C. van, Etten E., Decallonne B., Guilietti A., Gyse- mans C., Bouillon R., Overbergh L. Vitamin D and 1,25-dihydroxyvitamin D3 as modulators in the immune system J. Steroid Biochem. and Mol. Biol. 2004. 89-90, N 1-5. P. 449-452.
34. Adams J. S., Liu P. T., Chun R., Modlin R. L., Hewison M. Vitamin D in defense of the human immune response. Ann. N. Y. Acad. Sci. 2007. 1117. P. 94-105.
35. Liu H., Redline R. W., Han Y. W. Fusobacterium nucleatum induces fetal death in mice via stimulation of TLR4-mediated placental inflammatory response. J. Immunol. 2007. 179, N 4. P. 2501-2508.
36. Cantorna M. T., Zhu Y., Froicu M., Wittke A. Vitamin D status, 1,25-dihydroxyvitamin D3, and the immune system. Am. J. Clin. Nutr. 2004. 80, N 6, suppl. P. 1717S-1720S.
37. Griffin M. D., Xing N., Kumar R. Vitamin D and its analogs as regulators of immune activation and antigen presentation. Ann. Rev. Nutr. 2003. 23. P. 117-145.
38. Deluca H. F., Cantorna M. T. Vitamin D: its role and uses in immunology. FASEB J. 2001. 15, N 14. P. 2579-2585.
39. Townsend K., Evans K. N., Campbell M. J., Colston K. W., Adams J. S., Hewison M. Biological actions of extra-renal 25-hydroxyvitamin D-1alpha-hydroxylase and implications for chemoprevention and treatment. J. Steroid Biochem. and Mol. Biol. 2005. 97, N 1-2. P. 103-109.
40. Hewison M., Zehnder D., Chakraverty R., Adams J. S. Vitamin D and barrier function: a novel role for extra-renal 1 alpha-hydroxylase. Mol. and Cell. Endocrinol. 2004. 215, N 1-2. P. 31-38.
41. Kreutz M., Andreesen R., Krause S. W., Szabo A., Ritz E., Reichel H. 1,25-dihydroxyvitamin D3 production and vitamin D3 receptor expression are developmentally regulated during differentiation of human monocytes into macrophages. Blood. 1993. 82, N 4. P. 1300-1307.
42. Hewison M., Freeman L., Hughes S. V., Evans K. N., Bland R., Eliopoulos A. G., Kilby M. D., Moss P. A., Chakraverty R. Differential regulation of vitamin D receptor and its ligand in human monocyte-derived dendritic cells. J. Immunol. 2003. 170, N 11. P. 5382-5390.
43. Gray T. K., Lester G. E., Lorenc R. S. Evidence for extra-renal 1 alpha-hydroxylation of 25-hydroxyvitamin D3 in pregnancy. Science. 1979. 204, N 4399. P. 1311-1313.
44. Weisman Y., Harell A., Edelstein S., David M., Spirer Z., Go-lander A. 1 alpha, 25-Dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3 in vitro synthesis by human decidua and placenta. Nature. 1979. 281, N 5729. P. 317-319.
45. Bruns M. E., Bruns D. E. Vitamin D metabolism and function during pregnancy and the neonatal period. Ann. Clin. Lab. Sci. 1983. 13, N 6. P. 521-530.
46. Rebut-Bonneton C., Demignon J. Effects of 1,25-dihydroxy vitamin D3 on in vitro lymphocyte reactions: arguments for a role at the maternofetal interface. Gynecol. Obstet. Invest. 1991. 32, N 3. P. 134-138.
47. Sacks G., Sargent I., Redman C. An innate view of human pregnancy. Immunol. Today. 1999. 20, N 3. P. 114-118.
48. Guleria I., Pollard J. W. The trophoblast is a component of the innate immune system during pregnancy. Nat. Med. 2000. 6, N 5. P. 589-593.
49. Zenclussen A. C., Schumacher A., Zenclussen M. L., Wafula P., Volk H. D. Immunology of pregnancy: cellular mechanisms allowing fetal survival within the maternal uterus. Expert Rev. Mol. Med. 2007. 9, N 10. P. 1-14.
50. Laskarin G., Kammerer U., Rukavina D., Thomson A. W., Fernandez N., Blois S. M. Antigen-presenting cells and materno-fetal tolerance: an emerging role for dendritic cells. Am. J. Reprod. Immunol. 2007. 58, N 3. P. 255-267.
51. Liu P. T., Stenger S., Li H., Wenzel L., Tan B. H., Krutzik S. R., Ochoa M. T., Schauber J., Wu K., Meinken C., Kamen D. L., Wagner M., Bals R., Steinmeyer A., Zugel U., Gallo R. L., Eisenberg D., Hewison M., Hollis B. W., Adams J. S., Bloom B. R., Modlin R. L. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science. 2006. 311, N 5768. P. 1770-1773.
52. Adams J. S., Hewison M. Unexpected actions of vitamin D: new perspectives on the regulation of innate and adaptive immunity. Nat. Clin. Pract. Endocrinol. Metabol. 2008. 4, N 2. P. 80-90.
53. Bodnar L. M., Krohn M. A., Simhan H. N. Maternal vitamin D deficiency is associated with bacterial vaginosis in the first trimester of pregnancy. J. Nutr. 2009. 139, N 6. P. 1157-1161.
54. Fiscella K. Racial disparity in infant and maternal mortality: confluence of infection, and microvascular dysfunction. Matern. and Child Health J. 2004. 8, N 2. P. 45-54.